Richard A. Norman

2.3k citations

26 papers · 1.5k indexed · h-index 18

Molecular Biology top 10%
Organic Chemistry top 10%
Oncology top 10%
Computational Theory and Mathematics top 5%
Cancer Research

Co-authors: J. Breed Alexander L. Breeze Julie A. Tucker Chris Phillips Rémy Morgentin Patrick A. Plé Richard A. Pauptit Gerard Costello
Topics: Fibroblast Growth Factor Research (6 papers)Biochemical and Molecular Research (4 papers)Kruppel-like factors research (4 papers)
Cited by: Molecular Biology Organic Chemistry Computational Theory and Mathematics
Journals: Journal of Biological Chemistry Nature Communications The EMBO Journal
Partner nations: United Kingdom United States Netherlands

In The Last Decade

Richard A. Norman

26 papers receiving 1.5k citations

Peers

Countries citing papers authored by Richard A. Norman

Since Specialization

Citations

This map shows the geographic impact of Richard A. Norman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard A. Norman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard A. Norman more than expected).

Fields of papers citing papers by Richard A. Norman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard A. Norman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard A. Norman. The network helps show where Richard A. Norman may publish in the future.

Co-authorship network of co-authors of Richard A. Norman

This figure shows the co-authorship network connecting the top 25 collaborators of Richard A. Norman. A scholar is included among the top collaborators of Richard A. Norman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard A. Norman. Richard A. Norman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Validation of ion mobility spectrometry ‐ mass spectrometry as a screening tool to identify type II kinase inhibitors of FGFR1 kinase 2021 ·Rapid Communications in Mass Spectrometry ·(unknown),Tobias Klein,Richard A. Norman,Julie A. Tucker,Malcolm Anderson,Alison E. Ashcroft,Geoffrey A. Holdgate	3
2	Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use 2016 ·Oncotarget ·(unknown),Tom D. Bunney,Nethaji Thiyagarajan,Richard A. Norman,D. Ogg,J. Breed,Paul Ashford,(unknown),Mina Edwards,Sarah V. Williams,(unknown),Camilla Pang,Margaret A. Knowles,Alexander L. Breeze,Christine Orengo,Chris Phillips,Matilda Katan	91
3	Structural and dynamic insights into the energetics of activation loop rearrangement in FGFR1 kinase 2015 ·Nature Communications ·Tobias Klein,Navratna Vajpai,Jonathan J. Phillips,Gareth M. Davies,Geoffrey A. Holdgate,Chris Phillips,Julie A. Tucker,Richard A. Norman,Andrew D. Scott,Daniel R. Higazi,David C. Lowe,Gary S. Thompson,Alexander L. Breeze	56
4	Tetrahydroisoquinoline Phenols: Selective Estrogen Receptor Downregulator Antagonists with Oral Bioavailability in Rat 2015 ·ACS Medicinal Chemistry Letters ·James S. Scott,Andrew Bailey,Robert D. M. Davies,Sébastien L. Degorce,Philip A. MacFaul,(unknown),Tom Moss,Richard A. Norman,Jennifer H. Pink,Alfred A. Rabow,Bryan Roberts,Peter D. Smith	29
5	Abstract 3650: Discovery of the clinical candidate AZD9496: a potent and orally bioavailable selective estrogen receptor downregulator and antagonist 2015 ·Cancer Research ·Chris De Savi,Robert H. Bradbury,Alfred A. Rabow,Richard A. Norman,David Buttar,Gordon S. Currie,Hazel M. Weir,Craig S. Donald,David W. Andrews,(unknown),Peter Ballard,Jon Curwen,Zena Wilson,Graham H.P. Richmond,Celina M. D’Cruz,Steve Powell,Graeme E. Walker,Michael Hulse,Michael Tonge	4
6	Structural Insights into FGFR Kinase Isoform Selectivity: Diverse Binding Modes of AZD4547 and Ponatinib in Complex with FGFR1 and FGFR4 2014 ·Structure ·Julie A. Tucker,Tobias Klein,J. Breed,Alexander L. Breeze,R. Overman,Chris Phillips,Richard A. Norman	97
7	Characterization of the complex formed between a potent neutralizing ovine-derived polyclonal anti-TNFα Fab fragment and human TNFα 2013 ·Bioscience Reports ·W. Mark Abbott,(unknown),(unknown),(unknown),Gareth M. Davies,Richard A. Norman,(unknown),Jerry W. Slootstra,Joris J. Benschop,Yoshitomo Hamuro,(unknown),Peter Newham	7
8	Safety Observations: How a National Laboratory Uses BBS to Improve Its Emergency Program 2012 ·Professional safety ·Michael E. Cournoyer,(unknown),(unknown),Richard A. Norman	2
9	Structural approaches to obtain kinase selectivity 2012 ·Trends in Pharmacological Sciences ·Richard A. Norman,Dorin Toader,Andrew D. Ferguson	58
10	Design and Synthesis of Novel Lactate Dehydrogenase A Inhibitors by Fragment-Based Lead Generation 2012 ·Journal of Medicinal Chemistry ·Richard A. Ward,C. Brassington,Alexander L. Breeze,Alessandro T. Caputo,Susan E. Critchlow,Gareth M. Davies,Louise Goodwin,(unknown),Ryan Greenwood,Geoffrey A. Holdgate,Michael Mrosek,Richard A. Norman,Stuart E. Pearson,Jonathan Tart,Julie A. Tucker,Martin Vogtherr,David Whittaker,Jonathan Wingfield,Jon Winter,Kevin Hudson	126
11	Rapid Generation of a High Quality Lead for Transforming Growth Factor-β (TGF-β) Type I Receptor (ALK5) 2009 ·Journal of Medicinal Chemistry ·Frederick W. Goldberg,Richard A. Ward,Steven J. Powell,J.E. Debreczeni,Richard A. Norman,Nicola Roberts,Allan Dishington,(unknown),(unknown),Andrew Roberts	33
12	N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a Novel, Highly Selective, Orally Available, Dual-Specific c-Src/Abl Kinase Inhibitor 2006 ·Journal of Medicinal Chemistry ·Laurent Hennequin,J M Allen,J. Breed,Jon Curwen,Michael Fennell,Tim P. Green,Christine Lambert‐van der Brempt,Rémy Morgentin,Richard A. Norman,Annie Olivier,Ludovic R. Otterbein,Patrick A. Plé,Nicolas Warin,Gerard Costello	283
13	Prevention of MKK6-Dependent Activation by Binding to p38α MAP Kinase 2005 ·Biochemistry ·Jane E. Sullivan,Geoffrey A. Holdgate,Douglas A. Campbell,David Timms,S. Gerhardt,J. Breed,Alexander L. Breeze,Alun Bermingham,Richard A. Pauptit,Richard A. Norman,Kevin J. Embrey,Jon Read,(unknown),Walter H.J. Ward	75
14	Crystal Structure of Human Thymidine Phosphorylase in Complex with a Small Molecule Inhibitor 2004 ·Structure ·Richard A. Norman,Simon T. Barry,(unknown),J. Breed,(unknown),(unknown),Richard Luke,Claire A. Minshull,M. McAlister,Eileen McCall,Helen McMiken,D. Paterson,David Timms,Julie A. Tucker,Richard A. Pauptit	86
15	Imidazo[1,2- b ]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Kate F. Byth,Nicola J. Cooper,Janet D. Culshaw,(unknown),(unknown),Claire A. Minshull,Richard A. Norman,Richard A. Pauptit,Julie A. Tucker,J. Breed,Andrew Pannifer,Siân Rowsell,(unknown),(unknown),Andrew P. Thomas	64
16	The Mycobacterium tuberculosis ino1 gene is essential for growth and virulence 2003 ·Molecular Microbiology ·Farahnaz Movahedzadeh,Debbie A. Smith,Richard A. Norman,Premkumar Dinadayala,Judith Murray‐Rust,David G. Russell,Sharon L. Kendall,Stuart Rison,M. McAlister,Gregory J. Bancroft,Neil Q. McDonald,Mamadou Daffé,Yossef Av‐Gay,Neil G. Stoker	75
17	Imidazo[1,2-a]pyridines: A potent and selective class of cyclin-Dependent kinase inhibitors identified through structure-Based hybridisation 2003 ·Bioorganic & Medicinal Chemistry Letters ·Malcolm Anderson,(unknown),Gloria A. Breault,J. Breed,(unknown),Janet D. Culshaw,Rebecca Ellston,Stephen Green,Claire A. Minshull,Richard A. Norman,Richard A. Pauptit,(unknown),Andrew P. Thomas,Philip J. Jewsbury	95
18	Crystal Structure of Inositol 1-Phosphate Synthase from Mycobacterium tuberculosis, a Key Enzyme in Phosphatidylinositol Synthesis 2002 ·Structure ·Richard A. Norman,M. McAlister,Judith Murray‐Rust,Farahnaz Movahedzadeh,Neil G. Stoker,Neil Q. McDonald	51
19	Steric Hindrance Regulation of the Pseudomonas aeruginosa Amidase Operon 2000 ·Journal of Biological Chemistry ·Richard A. Norman,Chit Laa Poh,Laurence H. Pearl,B.P. O'Hara,Robert E. Drew	16
20	Voltage- and time-dependent potassium conductances enhance the frequency response of horizontal cells in the turtle retina 1993 ·Brain Research ·Ido Perlman,(unknown),Richard A. Norman	8

About Richard A. Norman

Richard A. Norman is a scholar working on Chemical Health and Safety, Toxicology and Molecular Biology, having authored 26 papers that have together received 1.5k indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (6 papers), Biochemical and Molecular Research (4 papers) and Kruppel-like factors research (4 papers). The work is most often cited by research in Molecular Biology (1.0k citations), Organic Chemistry (325 citations) and Computational Theory and Mathematics (165 citations). Richard A. Norman has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include J. Breed, Alexander L. Breeze, Julie A. Tucker, Chris Phillips, Rémy Morgentin, Patrick A. Plé, Richard A. Pauptit, Gerard Costello, Nicolas Warin and Jon Curwen. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact